NCT05298605 Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
| NCT ID | NCT05298605 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cedars-Sinai Medical Center |
| Condition | Breast Cancer Female |
| Study Type | INTERVENTIONAL |
| Enrollment | 320 participants |
| Start Date | 2022-07-16 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 320 participants in total. It began in 2022-07-16 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to develop a culturally adapted "Faith in Action!" curriculum to train lay health navigators to provide breast cancer screening navigation to Korean American women within faith-based settings and evaluate whether the culturally adapted "Faith in Action!" curriculum increases adherence to breast cancer screening guidelines among Korean American women within faith-based settings in Los Angeles, California. The primary research procedures include trainings and key informant interviews with lay health navigators in faith-based settings followed by a cluster randomized trial to evaluate the intervention.
Eligibility Criteria
Inclusion Criteria: * Korean woman who is 45 years or older * Does not currently have a breast cancer diagnosis * Non-adherent to cancer screening (did not receive mammogram in last 2 years based on self-report) * Prospective or current member of participating Korean Churches * Willing to participate in study Exclusion Criteria: * Does not meet inclusion criteria as described above
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05298605 clinical trial?
This trial is open to female participants only, aged 45 Years or older, up to 80 Years, studying Breast Cancer Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05298605 currently recruiting?
Yes, NCT05298605 is actively recruiting participants. Contact the research team at Robert.haile@cshs.org for enrollment information.
Where is the NCT05298605 trial being conducted?
This trial is being conducted at Los Angeles, United States, Los Angeles, United States.
Who is sponsoring the NCT05298605 clinical trial?
NCT05298605 is sponsored by Cedars-Sinai Medical Center. The trial plans to enroll 320 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.